Adare Pharmaceuticals

Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.

Orbis Biosciences offers the ability to control the size, encapsulation material, shell thickness, and porosity of nearly any material with a level of scalability that has, until now, been impossible. From drug formulations, to agricultural compounds to novel food processing techniques, we can provide solutions to any size problem.